Next Article in Journal
The Management of Postoperative Recurrence in Crohn’s Disease
Previous Article in Journal
An Artificial Intelligence System for Optimizing Radioactive Iodine Therapy Dosimetry
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
JCM
Volume 13
Issue 1
10.3390/jcm13010118
jcm-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Evaluation of Self-Management Behaviors and Its Correlation with the Metabolic Syndrome among the Type 2 Diabetes Mellitus Patients of Northern Saudi Arabia

by
Aseel Awad Alsaidan
1,*,
Ashokkumar Thirunavukkarasu
1,
Hassan H. Alhassan
2,
Ibrahim Abdullah Bin Ahmed
3,
Anas Salem Alnasiri
4,
Wejdan Madallah Alhirsan
5,
Nouf Nashmi M. Alazmi
5,
Abdalaziz Khaled Alkhlaf
5,
Jumanah Mohammed Alderbas
5 and
Motaz Abdulsalam Alkhaldi
5
1
Department of Family and Community Medicine, College of Medicine, Jouf University, Sakaka 72388, Saudi Arabia
2
Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Jouf University, Sakaka 72388, Saudi Arabia
3
Department of Family Medicine, College of Medicine, Imam Mohammad Ibn Saud Islamic University, Riyadh 11432, Saudi Arabia
4
King Abdulaziz Specialist Hospital, Ministry of Health, Sakaka 72345, Saudi Arabia
5
College of Medicine, Jouf University, Sakaka 72388, Saudi Arabia
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2024, 13(1), 118; https://doi.org/10.3390/jcm13010118
Submission received: 25 November 2023 / Revised: 16 December 2023 / Accepted: 21 December 2023 / Published: 25 December 2023
(This article belongs to the Section Endocrinology & Metabolism)
Browse Figures
Review Reports Versions Notes

Abstract

:
Self-management behavior among diabetes patients is essential to monitor blood sugar levels, make necessary lifestyle changes, and help patients reduce their risk of complications from diabetes. We assessed the prevalence of metabolic syndrome (MS) and its association with self-management behavior and sociodemographic characteristics among 310 patients with type 2 diabetes mellitus (T2DM) attending different diabetes care centers in northern Saudi Arabia. We evaluated the self-management behaviors of patients with T2DM using a validated Arabic version of the Summary of Diabetes Self-Care Activities Scale. Regarding MS, we applied the National Cholesterol Education Program (NCEP) Adult Treatment Plan–3 (ATP–3) guidelines. A logistic regression analysis was used to identify the predictors of MS. We found that more than one-third (36.5%) of patients had MS according to the NCEP ATP-3 criteria. The prevalence of MS was significantly associated with unsatisfactory self-management behaviors. Regarding sociodemographic predictors for MS, we found a significant association between gender (ref: female: Adjusted OR (AOR) = 1.89, 95%CI = 1.17–2.95, p = 0.007) and body mass index (ref.: normal range: AOR = 2.98, 95%CI = 1.31–5.07, p = 0.003). Our findings suggest a tailor-made multifaceted intervention to improve the self-management behaviors of T2DM patients, which, in turn, can reduce MS.

1. Introduction

The prevalence of type 2 diabetes mellitus (T2DM) in recent years has become a significant global health problem. Research shows that T2DM is the most common and clinically crucial pathophysiologic disorder [1,2]. By 2045, projections from the International Diabetes Federation (IDF) indicate that one in every eight adults, about 783 million, will live with diabetes [3]. The prevalence of T2DM is rising rapidly not only in developed countries but also in developing countries like the Kingdom of Saudi Arabia (KSA) also observed an increasing prevalence [3,4]. This could be due to the aging population, obesity, and sedentary lifestyle [5,6]. For many years, T2DM was considered an adult disease, but with the rising teenage and child obesity cases, this phenomenon has changed [7,8].
Managing this major public health problem necessitates a multidimensional approach that includes self-care behaviors [9]. Self-management behavior is essential for people with diabetes because it helps them monitor their blood sugar levels and change their diet and exercise habits if necessary [9]. Hence, their quality of life can be significantly improved [10]. Self-management behavior can also assist patients to reduce their risk of complications from diabetes. Several types of self-management behavior, including diet, exercise, medication management, and communication, are essential in the care process for type 2 diabetic patients [9,11,12]. Diet is one of the most critical types of self-management behavior for people with diabetes [9,13]. People with diabetes should follow a healthy diet with plenty of fruits and vegetables, whole grains, low-fat dairy products, and lean protein sources. They should also avoid sugar-sweetened beverages, processed foods, and excessive amounts of salt [14,15]. Exercise is also crucial for people with diabetes. They should aim for at least 30 min of physical activity per day. Moderate-intensity exercise (such as brisk walking) is best for diabetes patients, while vigorous-intensity exercise (such as running) may be too strenuous. Medication management is another crucial type of self-management behavior for people with diabetes [16].
As the prevalence of T2DM increases, so does the incidence of metabolic syndrome (MS). MS is a group of conditions that increase the risk of developing stroke and cardiovascular events [17,18]. A study conducted by Ji M et al. in China stated that self-management behaviors, especially physical activity, are one of the critical predictors that were associated with MS among patients with diabetes in their study [19]. In evaluating the self-management behaviors among Saudi T2DM patients by Alodhayani A et al. in 2021, they revealed that gender and marital status were the significant associated factors [20]. Another study from Jordan among T2DM patients stated that nearly three-fourths of their participants had unsatisfactory self-management behavior [21]. The prevalence of MS among Saudi diabetic patients is relatively high, which increases the chance of serious health complications occurring [22]. However, there is limited research on self-management behavior and correlation with MS among T2DM patients in Saudi Arabia, especially in the Aljouf region of KSA. This means we do not know how well it works or what its effects are on people’s quality of life, so we need to do more research in this area.
Furthermore, an ongoing assessment of the epidemiological data related to self-management is essential, as these behaviors are constantly changing. Additionally, this research could contribute to the existing literature and to the understanding of healthcare professionals of how self-management behavior can improve people’s diabetes outcomes. Therefore, the present study was aimed to assess the self-management behaviors and their correlations with MS and other sociodemographic characteristics of the T2DM patients attending outpatient diabetes care clinics.

2. Participants and Methods

2.1. Study Design

This study is a quantitative cross-sectional study that was conducted from May 2023 to November 2023.

2.2. Study Setting

The present study’s patients were selected from those attending outpatient diabetes care clinics in the Aljouf region of KSA. This region is located close to Jordan in the northern part of KSA. The present study included adult T2DM patients (18 years and older) attending outpatient diabetes care clinics. We excluded the other forms of diabetes, inpatients, newly diagnosed patients, and those unwilling to participate.

2.3. Sampling Method

We have used the open-source, freely available Raosoft online sample size calculator to find the minimum number of T2DM patients required for this survey [23]. The Raosoft calculator uses the same sampling strategies as the WHO and Cochran sample size estimation formula (n = z2pq/e2). The research team considered anticipated self-management behavior based on a study conducted by Almomani MH et al. (p = 20.8%) [21], an acceptable margin of error (e = 5%), and 80% power to estimate the sample size. However, the research team included an additional 20% of the sample size. Hence, the calculated minimum required sample size was 300.

2.4. Data Collection Steps

Firstly, we received the necessary ethical clearance and approvals from the concerned institutions to start the data collection. Next, after each patient’s follow-up at the outpatient clinic, we briefed the study objectives to the participants and obtained informed consent in accordance with the declaration of Helsinki. Next, we asked them to fill out a standard, a pretested Arabic version of the data collection proforma consisting of three sections. The collected data were anonymous and de-identified. The first section asked about the background of diabetes ’patients and health-related characteristics. After that, the data collectors recorded the following details in the second section from patients’ files: blood pressure level (systolic/diastolic) (mmHg), height (cm), weight (kgs), waist circumference (cms), and laboratory tests (fasting blood sugar and lipid profile). The included test results were from the latest visit laboratory results. We followed the National Cholesterol Education Program Adult Treatment Plan–3 (NCEP ATP–3) criteria as an operational definition to classify the presence or absence of MS among the participants. The NCEP ATP–3 criteria are one of the widely used criteria in clinical and epidemiological studies to assess MS [24]. Please find the criteria and values in Appendix A. We calculated the body mass index (BMI) using the standard formula [BMI = weight (kgs)/height (m2)]. Furthermore, we classified the BMI status of the patients according to the World Health Organization (WHO) classification [25]. Similarly, we followed the standard protocols to measure the waist circumference of the patients [26,27].
The third part of the questionnaire inquired about the diabetes patients’ self-care behavior. The Summary of Diabetes Self-Care Activities (SDSCA-Arabic), a widely used tool to assess self-care behaviors for diabetic patients, was used in the present study [21,28,29]. The questionnaire comprised five significant sectors to access following self-care for diabetes patients. Firstly, the diet sector includes general and specific diets containing two and three items, respectively. The blood glucose testing, medication, and exercise sectors are all made up of two things each. The remaining part of the questionnaire is the foot care sector, which consists of four components. Hence, a total of 15 questions were used to evaluate the self-management behavior of the participants. An eight-point Likert scale was used for the past week’s assessment of self-care performance frequency. The minimum frequency is zero days, while the maximum is seven days. In the diet sub-scale, high-fat consumption is assessed on item five. It is coded in reverse for accurate recording to display adherence to a low-fat diet for the diabetic patient. For each subscale, the mean score is calculated following the guidelines provided by SDSCA. Afterward, the overall average of the mean scores of the subscales is obtained. This average of the total score also ranged from zero to seven.
Different scores reflected different levels of self-care for diabetic patients. For example, higher scores reflect higher self-care than lower scores. We categorized the scores ranging from zero to four as unsatisfactory, whereas those ranging from five to seven were considered satisfactory. The SDSCA-Arabic has, over time, been proven to be reliable and valid. Furthermore, we pretested the Arabic version of SDSCA through the pilot study among 30 T2DM patients, and the Cronbach alpha value for the tool was 0.79.

2.5. Statistical Analysis

The survey team used Statistical Package for the Social Sciences (IBM SPSS Statistics for Windows, version 21.0, Armonk, NY, USA: IBM Corp.) for data curation and necessary statistical tests. We reported the descriptive data as numbers, proportion (%) for discrete data, and mean with standard deviation for the quantitative data. We executed Spearman’s correlation test (test value is presented as rho) to identify the correlation between the scores of each SDSCA item and the MS components. The research team performed a multivariate analysis (binomial logistic regression) to find the association between MS, self-management behaviors, and sociodemographic characteristics. A p-value of less than 0.05 was identified through binomial logistic regression and was considered a statistically significant variable.

3. Results

During the data collection period, we communicated with 353 T2DM patients, and 310 patients (more than minimum required) agreed to participate in the study (response rate = 87.8%). Of the patients who participated in the study, the majority were between 50 and 60 years old (40.6%), male (52.6%), married (75.8%), and non-smokers (79.7%). The mean ± SD of the duration of diabetes among the participants was 9.84 ± 5.23, and most patients were only on oral hypoglycemic agents (OHA) (Table 1).
Values of physical parameters, such as BMI (kg/m2), waist circumference (cm), systolic and diastolic BP (mmHg), and laboratory values of participants, are presented in Table 2.
Of the 310 participants, 34 patients BMI were within the normal range (11%), 110 (35.5%) were overweight, and 166 were obese (53.5%) (Figure 1).
Table 3 shows the mean and SD scores of each subscale and the overall scores of SDSCA. Our study observed the lowest scores for participating in a specific exercise session (mean = 1.84) and the highest scores for insulin injections according to the recommended schedule (mean = 5.93). After applying the set criteria (overall mean score < 4 is considered unsatisfactory, and from 4 to 7 is considered satisfactory), we found that about 69% of the patients’ self-care behaviors were unsatisfactory.
The Spearman correlation test revealed that the number of days following a healthy diet plan is negatively correlated with waist circumference (cms) (rho = −0.252 and p = 0.001) and fasting blood sugar (mmol/L) (rho = −0.260 and p = 0.001). In contrast, HDL level (mmol/L) was positively correlated with the healthy diet plan (rho = 0.168 and p = 0.003). Regarding physical activity, we found a positive correlation with HDL (mmol/L) (rho = 0.139 and p = 0.014) and negative correlation with the BMI (kg/m2) (rho = −0.206 and p = 0.001). On adhering to the treatment regimen, fasting blood sugar (mmol/L) was significantly and negatively associated with both insulin (rho = −0.311 and p = 0.001) and OHA (rho = −0.250 and p = 0.006) adherence (Table 4).
After applying the NCEP ATP 3 criteria, we found that 36.5% of the patients in the present study were considered to have MS (Figure 2).
After adjusting other variables in binary logistic regression, the presence of MS among the participants was significantly associated with gender (ref: Males: adjusted OR [AOR] = 1.89, 95%CI = 1.17–2.95, p = 0.007), smoking status (ref: Non-smokers: AOR = 1.56, 95% CI = 1.56 (1.17–2.41, p = 0.016), self-management behavior (ref.: satisfactory: AOR = 1.55, 95%CI = 1.11–2.87, p = 0.027), body mass index (ref.: normal range: AOR = 2.98, 95%CI = 1.31–5.07, p = 0.003), and the presence of comorbid conditions (ref: No: AOR = 1.74, 95% CI = 1.11–2.67, p = 0.006) (Table 5).

4. Discussion

Globally, the significance of a holistic and multidimensional approach is proven, not only when it comes to T2DM but also to the cluster of comorbidities that may be associated, including MS [17]. The present study evaluated self-management behavior and its association with MS and sociodemographic factors among the T2DM patients.
Regarding self-management behavior, the present study found the lowest scores in participating in a specific exercise session and the highest scores in taking insulin injections according to the recommended schedule. Interestingly, a study conducted in a tertiary care center in the KSA and another study by Almomani et al. also found that the lowest score was in exercise sessions and the highest score on the medication adherence scale; however, their scores were slightly higher than the present study in most of the subscales [21,30]. Even though a community-based survey conducted in India among diabetes patients showed similar trend findings across the subscales of self-management behavior, their participants’ overall scores were lower than our study [31]. We identified the major area of concern in self-care management, which is regular exercise, an essential component of self-care behavior that is to be followed. In addition to routine diabetes care, healthcare providers must consider giving special attention to improving regular exercise among T2DM patients, as exercise is proven to reduce the cluster of conditions of MS [32,33]. Our study findings were similar to the studies mentioned above. We found that those who followed more days of physical activities had low BMI, low TGL, and high HDL.
One of the positive and encouraging findings identified in the present study was that the highest mean score was observed in the number of days adhering to insulin injection (mean = 5.93), followed by OHA intake (mean 5.72). Furthermore, adhering to the treatment regimen for more days negatively correlates with fasting blood sugar (less). These findings indirectly indicate the medication adherence practice among T2DM patients. The relatively good adherence suggests the impact of previous studies and incorporating their suggestions into the diabetes care plan [34,35,36]. According to the overall score’s categorization, over two-thirds of the study participants had unsatisfactory self-management behaviors. This finding is similar to several studies conducted among diabetes patients, indicating that self-management behaviors need to be specially addressed by policymakers [21,37,38,39].
The present study revealed that 36.5% of the T2DM patients identified having MS, a clinically significant finding for healthcare providers and policymakers. Previous researchers reported wide variations in the prevalence of MS [17,40,41,42]. These variations are due to operational definitions of MS, healthcare settings of the included patients, and availability of healthcare services. These findings from the present study and other studies are noteworthy as they underscore the high prevalence of MS among diabetes patients. Furthermore, these revealed findings insist on the interconnection of diabetes and MS, which share common risk factors and pathological pathways. The presence of these disorders together can have a synergistic effect, increasing the likelihood of developing more complications of T2DM [43,44]. Hence, clinicians and policymakers consider implementing regular screening to identify the cluster of risk factors related to MS to prevent or delay complications.
We found that MS among the T2DM patients was significantly associated with self-management behavior. Similar to the present finding, Ji M et al. in China found a significant positive correlation between MS and self-management behavior, especially the physical activity subscale [19]. It is worth mentioning here again that the exercise subscale mean score of the present study was the lowest among all subscales. One of the most likely reasons might be the bi-directional association between self-management and MS. Numerous pieces of evidence suggest that patients who were identified with MS tend to have a higher risk of developing depression and a lack of support for social activities that help them to implement self-management behaviors such as exercise and diet [45,46]. Simultaneously, poor diabetic self-management behaviors may lead to the development or worsening of MS [46,47].
Other critically associated factors of MS that were identified through logistic regression analysis were gender, smoking, and BMI. Considering the conservative nature of Saudi society and sociocultural reasons, the gender differences in the prevalence of MS are a noteworthy finding. Some authors have found a similar association, while some other studies varied in their conclusions [19,48,49]. The differences might be due to sociocultural settings and the presence of other comorbidities. Interestingly, a study performed by Du S et al. found that MS was predominantly higher among males than females [50]. Nonetheless, the influence of gender-specific variation in the prevalence of MS indicates tailor-made, gender-specific targeted intervention strategies are required to reduce the MS burden among T2DM patients. Another important finding of the present study was smokers had higher odds of developing MS among T2DM patients than non-smokers, indicating the role of smoking on the development of MS. Hence, smoking is a non-modifiable risk factor, regular targeted health education and smoking cessation sessions are to be taken to the patients. The strong association between BMI and MS in the present study is consistent with the existing literature, suggesting that weight management programs for diabetes are to be implemented as a part of routine diabetes care [51,52]. For instance, Kobo O et al. stated that BMI is a significant factor with a strong negative predictive value, and the presence of normal BMI is one of the highly supporting pieces of evidence to rule out MS [53]. Healthcare providers and policymakers can take the practical values of these findings in the following ways. Firstly, the risk factors can be used as surrogate markers to identify the T2DM patients who are at risk of presenting MS. Hence, tailored and early intervention strategies can be implemented through the multidisciplinary approach. Furthermore, through health education programs using a multidisciplinary approach, the healthcare providers should support the patients’ empowerment, as self-management behavior among T2DM patients can be attained primarily through patient empowerment [9,54,55,56].
The research team made the best possible attempt with a standard method for this study. The present study provides valuable insights into one of the important and rising health problems. We used a standard and validated tool to evaluate the self-management behavior of T2DM that can help the policymakers to implement necessary measures. Nonetheless, the following constraints are to be noted while interpreting this paper. Firstly, the present study recruited T2DM patients from outpatient diabetes care centers; hence, the findings cannot be the same for the inpatients and other forms of diabetes. Next, considering the nature of the cross-sectional study design, we could not evaluate the causal association between MS and self-management behaviors. Finally, considering the wide range of differences in socio-economic and cultural settings in the KSA, this study’s findings may not be applicable to other regions.

5. Conclusions

The present study observed that a high proportion of T2DM patients identified with MS. The self-management behaviors towards diabetes care were unsatisfactory among more than two-thirds of patients. Prevalence of MS is significantly associated with unsatisfactory self-management behaviors, gender, smokers, and BMI status. Our study findings suggest that tailor-made targeted measures aimed at improving the self-management behaviors of T2DM patients. Thus, implementing adequate self-management behaviors can help in achieving optimal clinical outcomes in patients with T2DM. Hence, the patients can effectively participate in their care through diet and physical activity modifications, adhering to treatment plans, and periodic health monitoring. Furthermore, we recommend conducting prospective exploratory studies across different regions of KSA to recognize the region-specific intervention measures and temporal association.

Author Contributions

Conceptualization, A.A.A., A.T., H.H.A., I.A.B.A. and A.S.A.; methodology, A.A.A., W.M.A., N.N.M.A., A.K.A., J.M.A. and M.A.A.; software, A.T., A.S.A. and J.M.A.; validation, A.A.A., H.H.A., I.A.B.A., A.K.A. and N.N.M.A.; formal analysis, A.T., H.H.A., A.K.A. and M.A.A.; investigation, A.A.A., A.S.A. and J.M.A.; resources, A.A.A. and A.T.; data curation, W.M.A., N.N.M.A., A.K.A., J.M.A. and M.A.A.; writing—original draft preparation, A.A.A., I.A.B.A., A.S.A., N.N.M.A. and M.A.A.; writing—review and editing, A.T., H.H.A., W.M.A., A.K.A. and J.M.A.; visualization, A.T. and H.H.A.; supervision, A.A.A. and I.A.B.A.; project administration, A.T.; funding acquisition, A.A.A. All authors have read and agreed to the published version of the manuscript.

Funding

This work was funded by the Deanship of Graduate Studies and Scientific Research at Jouf University under grant No (DSR2023-01-02531).

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki and approved by the Qurrayat Health Affairs (Project no: 2023-63).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

The data presented in this study are available on request from the corresponding author. The data are not publicly available due to ethical reasons.

Acknowledgments

Authors wish to thank all participated patients. We extend our sincere thanks to the ministry of health affairs, Aljouf region for their immense support.

Conflicts of Interest

The authors declare no conflicts of interest.

Appendix A

Appendix A—NCEP ATP–3 criteria table that was used in the present study.

References

  1. Reed, J.; Bain, S.; Kanamarlapudi, V. A Review of Current Trends with Type 2 Diabetes Epidemiology, Aetiology, Pathogenesis, Treatments and Future Perspectives. Diabetes Metab. Syndr. Obes. 2021, 14, 3567–3602. [Google Scholar] [CrossRef] [PubMed]
  2. Goyal, R.; Singhal, M.; Jialal, I. Type 2 Diabetes. In StatPearls; StatPearls Publishing: Treasure Island, FL, USA, 2023. [Google Scholar]
  3. IDF. Diabetes: Facts and Figures. Available online: https://idf.org/about-diabetes/diabetes-facts-figures/ (accessed on 15 October 2023).
  4. Saeedi, P.; Petersohn, I.; Salpea, P.; Malanda, B.; Karuranga, S.; Unwin, N.; Colagiuri, S.; Guariguata, L.; Motala, A.A.; Ogurtsova, K.; et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res. Clin. Pract. 2019, 157, 107843. [Google Scholar] [CrossRef] [PubMed]
  5. Jarrar, M.; Abusalah, M.A.H.; Albaker, W.; Al-Bsheish, M.; Alsyouf, A.; Al-Mugheed, K.; Issa, M.R.; Alumran, A. Prevalence of Type 2 Diabetes Mellitus in the General Population of Saudi Arabia, 2000–2020: A Systematic Review and Meta-Analysis of Observational Studies. Saudi J. Med. Med. Sci. 2023, 11, 1–10. [Google Scholar] [CrossRef] [PubMed]
  6. Aljulifi, M.Z. Prevalence and reasons of increased type 2 diabetes in Gulf Cooperation Council Countries. Saudi Med. J. 2021, 42, 481–490. [Google Scholar] [CrossRef] [PubMed]
  7. Wu, H.; Patterson, C.C.; Zhang, X.; Ghani, R.B.A.; Magliano, D.J.; Boyko, E.J.; Ogle, G.D.; Luk, A.O.Y. Worldwide estimates of incidence of type 2 diabetes in children and adolescents in 2021. Diabetes Res. Clin. Pract. 2022, 185, 109785. [Google Scholar] [CrossRef] [PubMed]
  8. Perng, W.; Conway, R.; Mayer-Davis, E.; Dabelea, D. Youth-Onset Type 2 Diabetes: The Epidemiology of an Awakening Epidemic. Diabetes Care 2023, 46, 490–499. [Google Scholar] [CrossRef]
  9. Powers, M.A.; Bardsley, J.; Cypress, M.; Duker, P.; Funnell, M.M.; Fischl, A.H.; Maryniuk, M.D.; Siminerio, L.; Vivian, E. Diabetes Self-management Education and Support in Type 2 Diabetes: A Joint Position Statement of the American Diabetes Association, the American Association of Diabetes Educators, and the Academy of Nutrition and Dietetics. Clin. Diabetes 2016, 34, 70–80. [Google Scholar] [CrossRef] [PubMed]
  10. Babazadeh, T.; Dianatinasab, M.; Daemi, A.; Nikbakht, H.A.; Moradi, F.; Ghaffari-Fam, S. Association of Self-Care Behaviors and Quality of Life among Patients with Type 2 Diabetes Mellitus: Chaldoran County, Iran. Diabetes Metab. J. 2017, 41, 449–456. [Google Scholar] [CrossRef]
  11. Lin, H.C.; Tseng, C.W.; Hsieh, P.J.; Liang, H.L.; Sue, S.P.; Huang, C.Y.; Lee, M.Y. Efficacy of Self-Management on Glucose Control in Type 2 Diabetes Mellitus Patients Treated with Insulin. Healthcare 2022, 10, 2080. [Google Scholar] [CrossRef]
  12. Shrivastava, S.R.; Shrivastava, P.S.; Ramasamy, J. Role of self-care in management of diabetes mellitus. J. Diabetes Metab. Disord. 2013, 12, 14. [Google Scholar] [CrossRef]
  13. Matpady, P.; Maiya, A.G.; Saraswat, P.P.; Mayya, S.S.; Pai, M.S.; Anupama, D.S.; Umakanth, S. Dietary self-management practices among persons with T2DM: An exploratory qualitative study from western-coast of India. Diabetes Metab. Syndr. 2020, 14, 2161–2167. [Google Scholar] [CrossRef] [PubMed]
  14. Gray, A.; Threlkeld, R.J. Nutritional Recommendations for Individuals with Diabetes. In Endotext; Feingold, K.R., Anawalt, B., Blackman, M.R., Boyce, A., Chrousos, G., Corpas, E., de Herder, W.W., Dhatariya, K., Dungan, K., Hofland, J., et al., Eds.; MDText.com, Inc.: South Dartmouth, MA, USA, 2000. [Google Scholar]
  15. Petroni, M.L.; Brodosi, L.; Marchignoli, F.; Sasdelli, A.S.; Caraceni, P.; Marchesini, G.; Ravaioli, F. Nutrition in Patients with Type 2 Diabetes: Present Knowledge and Remaining Challenges. Nutrients 2021, 13, 2748. [Google Scholar] [CrossRef] [PubMed]
  16. Pan, L.; Zhang, X.; Wang, S.; Zhao, N.; Zhao, R.; Ding, B.; Li, Y.; Miao, W.; Fan, H. Determinants associated with self-management behavior among type 2 diabetes patients in China: A structural equation model based on the theory of planned behavior. Int. J. Clin. Health Psychol. 2023, 23, 100332. [Google Scholar] [CrossRef] [PubMed]
  17. Regufe, V.M.G.; Pinto, C.; Perez, P. Metabolic syndrome in type 2 diabetic patients: A review of current evidence. Porto Biomed. J. 2020, 5, e101. [Google Scholar] [CrossRef] [PubMed]
  18. Hayden, M.R. Overview and New Insights into the Metabolic Syndrome: Risk Factors and Emerging Variables in the Development of Type 2 Diabetes and Cerebrocardiovascular Disease. Medicina 2023, 59, 561. [Google Scholar] [CrossRef] [PubMed]
  19. Ji, M.; Ren, D.; Dunbar-Jacob, J.; Gary-Webb, T.L.; Erlen, J.A. Self-Management Behaviors, Glycemic Control, and Metabolic Syndrome in Type 2 Diabetes. Nurs. Res. 2020, 69, E9–E17. [Google Scholar] [CrossRef] [PubMed]
  20. Alodhayani, A.; Almutairi, K.M.; Vinluan, J.M.; Almigbal, T.H.; Alonazi, W.B.; Ali Batais, M.; Mohammed Alnassar, M. Association between self-care management practices and glycemic control of patients with type 2 diabetes mellitus in Saud Arabia: A cross -sectional study. Saudi J. Biol. Sci. 2021, 28, 2460–2465. [Google Scholar] [CrossRef]
  21. Almomani, M.H.; Al-Tawalbeh, S. Glycemic Control and Its Relationship with Diabetes Self-Care Behaviors among Patients with Type 2 Diabetes in Northern Jordan: A Cross-Sectional Study. Patient Prefer. Adherence 2022, 16, 449–465. [Google Scholar] [CrossRef]
  22. Ghamri, R.A.; Alamri, S.H. Metabolic syndrome among adults with type 2 diabetes in a Saudi teaching hospital: A comparative prevalence study using WHO and ATP III definitions. Pak. J. Med. Sci. 2019, 35, 1087–1092. [Google Scholar] [CrossRef]
  23. Raosoft. Sample Size Calculator by Raosoft, Inc. Available online: http://www.raosoft.com/samplesize.html (accessed on 12 February 2023).
  24. Grundy, S.M.; Cleeman, J.I.; Daniels, S.R.; Donato, K.A.; Eckel, R.H.; Franklin, B.A.; Gordon, D.J.; Krauss, R.M.; Savage, P.J.; Smith, S.C., Jr.; et al. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005, 112, 2735–2752. [Google Scholar] [CrossRef]
  25. WHO. Body Mass Index (BMI). Available online: https://www.who.int/data/gho/data/themes/topics/topic-details/GHO/body-mass-index (accessed on 18 August 2023).
  26. Ross, R.; Neeland, I.J.; Yamashita, S.; Shai, I.; Seidell, J.; Magni, P.; Santos, R.D.; Arsenault, B.; Cuevas, A.; Hu, F.B.; et al. Waist circumference as a vital sign in clinical practice: A Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity. Nat. Rev. Endocrinol. 2020, 16, 177–189. [Google Scholar] [CrossRef] [PubMed]
  27. Ma, W.Y.; Yang, C.Y.; Shih, S.R.; Hsieh, H.J.; Hung, C.S.; Chiu, F.C.; Lin, M.S.; Liu, P.H.; Hua, C.H.; Hsein, Y.C.; et al. Measurement of Waist Circumference: Midabdominal or iliac crest? Diabetes Care 2013, 36, 1660–1666. [Google Scholar] [CrossRef] [PubMed]
  28. Toobert, D.J.; Hampson, S.E.; Glasgow, R.E. The summary of diabetes self-care activities measure: Results from 7 studies and a revised scale. Diabetes Care 2000, 23, 943–950. [Google Scholar] [CrossRef] [PubMed]
  29. Sukkarieh-Haraty, O.; Howard, E. Psychometric Properties of the Arabic Version of the Summary of Diabetes Self-Care Activities Instrument. Res. Theory Nurs. Pract. 2016, 30, 60–69. [Google Scholar] [CrossRef] [PubMed]
  30. Alhaiti, A.H.; Senitan, M.; Dator, W.L.T.; Sankarapandian, C.; Baghdadi, N.A.; Jones, L.K.; Da Costa, C.; Lenon, G.B. Adherence of Type 2 Diabetic Patients to Self-Care Activity: Tertiary Care Setting in Saudi Arabia. J. Diabetes Res. 2020, 2020, 4817637. [Google Scholar] [CrossRef]
  31. Chandrika, K.; Das, B.N.; Syed, S.; Challa, S. Diabetes Self-Care Activities: A Community-Based Survey in an Urban Slum in Hyderabad, India. Indian J. Community Med. 2020, 45, 307–310. [Google Scholar] [CrossRef] [PubMed]
  32. Shah, S.Z.A.; Karam, J.A.; Zeb, A.; Ullah, R.; Shah, A.; Haq, I.U.; Ali, I.; Darain, H.; Chen, H. Movement is Improvement: The Therapeutic Effects of Exercise and General Physical Activity on Glycemic Control in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Diabetes Ther. 2021, 12, 707–732. [Google Scholar] [CrossRef]
  33. Cannata, F.; Vadalà, G.; Russo, F.; Papalia, R.; Napoli, N.; Pozzilli, P. Beneficial Effects of Physical Activity in Diabetic Patients. J. Funct. Morphol. Kinesiol. 2020, 5, 70. [Google Scholar] [CrossRef]
  34. Alanazi, M.; Alatawi, A.M. Adherence to Diabetes Mellitus Treatment Regimen among Patients with Diabetes in the Tabuk Region of Saudi Arabia. Cureus 2022, 14, e30688. [Google Scholar] [CrossRef]
  35. Alsaidan, A.A.; Alotaibi, S.F.; Thirunavukkarasu, A.; BF, A.L.; Alharbi, R.H.; Arnous, M.M.; Alsaidan, O.A.; Alduraywish, A.S.; Alwushayh, Y.A. Medication Adherence and Its Associated Factors among Patients with Type 2 Diabetes Mellitus Attending Primary Health Centers of Eastern Province, Saudi Arabia. Medicina 2023, 59, 989. [Google Scholar] [CrossRef]
  36. AlShayban, D.M.; Naqvi, A.A.; Alhumaid, O.; AlQahtani, A.S.; Islam, M.A.; Ghori, S.A.; Haseeb, A.; Ali, M.; Iqbal, M.S.; Elrggal, M.E.; et al. Association of Disease Knowledge and Medication Adherence among Out-Patients with Type 2 Diabetes Mellitus in Khobar, Saudi Arabia. Front. Pharmacol. 2020, 11, 60. [Google Scholar] [CrossRef] [PubMed]
  37. Maina, P.M.; Pienaar, M.; Reid, M. Self-management practices for preventing complications of type II diabetes mellitus in low and middle-income countries: A scoping review. Int. J. Nurs. Stud. Adv. 2023, 5, 100136. [Google Scholar] [CrossRef]
  38. Peng, X.; Guo, X.; Li, H.; Wang, D.; Liu, C.; Du, Y. A Qualitative Exploration of Self-Management Behaviors and Influencing Factors in Patients with Type 2 Diabetes. Front. Endocrinol. 2022, 13, 771293. [Google Scholar] [CrossRef] [PubMed]
  39. Ravi, S.; Kumar, S.; Gopichandran, V. Do supportive family behaviors promote diabetes self-management in resource limited urban settings? A cross sectional study. BMC Public Health 2018, 18, 826. [Google Scholar] [CrossRef]
  40. Asghar, S.; Asghar, S.; Shahid, S.; Fatima, M.; Bukhari, S.M.H.; Nadeem Siddiqui, S. Metabolic Syndrome in Type 2 Diabetes Mellitus Patients: Prevalence, Risk Factors, and Associated Microvascular Complications. Cureus 2023, 15, e39076. [Google Scholar] [CrossRef]
  41. Gemeda, D.; Abebe, E.; Duguma, A. Metabolic Syndrome and Its Associated Factors among Type 2 Diabetic Patients in Southwest Ethiopia, 2021/2022. J. Diabetes Res. 2022, 2022, 8162342. [Google Scholar] [CrossRef]
  42. do Vale Moreira, N.C.; Hussain, A.; Bhowmik, B.; Mdala, I.; Siddiquee, T.; Fernandes, V.O.; Montenegro Júnior, R.M.; Meyer, H.E. Prevalence of Metabolic Syndrome by different definitions, and its association with type 2 diabetes, pre-diabetes, and cardiovascular disease risk in Brazil. Diabetes Metab. Syndr. Clin. Res. Rev. 2020, 14, 1217–1224. [Google Scholar] [CrossRef]
  43. James, M.; Varghese, T.P.; Sharma, R.; Chand, S. Association between Metabolic Syndrome and Diabetes Mellitus According to International Diabetic Federation and National Cholesterol Education Program Adult Treatment Panel III Criteria: A Cross-sectional Study. J. Diabetes Metab. Disord. 2020, 19, 437–443. [Google Scholar] [CrossRef]
  44. Grabia, M.; Markiewicz-Żukowska, R.; Socha, K.; Polkowska, A.; Zasim, A.; Boruch, K.; Bossowski, A. Prevalence of Metabolic Syndrome in Relation to Cardiovascular Biomarkers and Dietary Factors among Adolescents with Type 1 Diabetes Mellitus. Nutrients 2022, 14, 2435. [Google Scholar] [CrossRef]
  45. Kim, H.-B.; Wolf, B.J.; Kim, J.-H. Association of metabolic syndrome and its components with the risk of depressive symptoms: A systematic review and meta-analysis of cohort studies. J. Affect. Disord. 2023, 323, 46–54. [Google Scholar] [CrossRef]
  46. Ghanei Gheshlagh, R.; Parizad, N.; Sayehmiri, K. The Relationship between Depression and Metabolic Syndrome: Systematic Review and Meta-Analysis Study. Iran. Red. Crescent Med. J. 2016, 18, e26523. [Google Scholar] [CrossRef] [PubMed]
  47. Lee, J.H.; Lee, K.H.; Kim, H.J.; Youk, H.; Lee, H.Y. Effective Prevention and Management Tools for Metabolic Syndrome Based on Digital Health-Based Lifestyle Interventions Using Healthcare Devices. Diagnostics 2022, 12, 1730. [Google Scholar] [CrossRef] [PubMed]
  48. Cohen, E.; Margalit, I.; Goldberg, E.; Krause, I. Gender as an Independent Risk Factor for the Components of Metabolic Syndrome among Individuals within the Normal Range of Body Mass Index. Metab. Syndr. Relat. Disord. 2018, 16, 537–542. [Google Scholar] [CrossRef] [PubMed]
  49. Ramezankhani, A.; Azizi, F.; Hadaegh, F. Gender differences in changes in metabolic syndrome status and its components and risk of cardiovascular disease: A longitudinal cohort study. Cardiovasc. Diabetol. 2022, 21, 227. [Google Scholar] [CrossRef] [PubMed]
  50. Du, S.; Zhang, H.; Wu, H.; Ye, S.; Li, W.; Su, Q. Prevalence and Gender Differences of Metabolic Syndrome in Young Ketosis-Prone Type 2 Diabetic Individuals: A Retrospective Study. Diabetes Metab. Syndr. Obes. 2020, 13, 2719–2727. [Google Scholar] [CrossRef] [PubMed]
  51. Arnlöv, J.; Sundström, J.; Ingelsson, E.; Lind, L. Impact of BMI and the metabolic syndrome on the risk of diabetes in middle-aged men. Diabetes Care 2011, 34, 61–65. [Google Scholar] [CrossRef] [PubMed]
  52. Alegría Ezquerra, E.; Castellano Vázquez, J.M.; Alegría Barrero, A. Obesity, Metabolic Syndrome and Diabetes: Cardiovascular Implications and Therapy. Rev. Esp. Cardiol. Engl. Ed. 2008, 61, 752–764. [Google Scholar] [CrossRef]
  53. Kobo, O.; Leiba, R.; Avizohar, O.; Karban, A. Normal body mass index (BMI) can rule out metabolic syndrome: An Israeli cohort study. Medicine 2019, 98, e14712. [Google Scholar] [CrossRef]
  54. Ernawati, U.; Wihastuti, T.A.; Utami, Y.W. Effectiveness of diabetes self-management education (DSME) in type 2 diabetes mellitus (T2DM) patients: Systematic literature review. J. Public Health Res. 2021, 10, jphr-2021. [Google Scholar] [CrossRef]
  55. Araújo-Soares, V.; Hankonen, N.; Presseau, J.; Rodrigues, A.; Sniehotta, F.F. Developing Behavior Change Interventions for Self-Management in Chronic Illness: An Integrative Overview. Eur. Psychol. 2019, 24, 7–25. [Google Scholar] [CrossRef]
  56. Cardoso Barbosa, H.; de Queiroz Oliveira, J.A.; Moreira da Costa, J.; de Melo Santos, R.P.; Gonçalves Miranda, L.; de Carvalho Torres, H.; Pagano, A.S.; Parreiras Martins, M.A. Empowerment-oriented strategies to identify behavior change in patients with chronic diseases: An integrative review of the literature. Patient Educ. Couns. 2021, 104, 689–702. [Google Scholar] [CrossRef] [PubMed]
Jcm 13 00118 g001
Figure 1. BMI categories (n = 310).
Figure 1. BMI categories (n = 310).
Jcm 13 00118 g001
Jcm 13 00118 g002
Figure 2. Prevalence of metabolic syndrome (MS) among T2DM patients of the present survey (n = 310).
Figure 2. Prevalence of metabolic syndrome (MS) among T2DM patients of the present survey (n = 310).
Jcm 13 00118 g002
Table 1. Sociodemographic characteristics of the participated type 2 diabetes mellitus (T2DM) patients (n = 310).
Table 1. Sociodemographic characteristics of the participated type 2 diabetes mellitus (T2DM) patients (n = 310).
VariablesFrequency (n)Proportion (%)
Age (mean ± SD)55.50 ± 11.06
Less than 50 years9129.4
From 50 to 60 years12640.6
More than 61 years9330.0
Gender
Male16352.6
Female14747.4
Educational qualification
No formal education.4614.8
Primary/Preparatory/Secondary17355.8
University/Graduate Studies9129.4
Occupation
Employee in a government sector8728.1
Employee in the private sector185.8
Unemployed11135.8
Retired9430.3
Married status
Single7524.2
Currently married23575.8
Monthly income in SAR (1 USD = 3.75 SAR)
Less than 5000 SAR10032.2
From 5000 to 1000 SAR10433.5
More than 10,000 SAR10634.3
Smoking status
No24779.7
Yes6320.3
Duration of T2DM (mean ± SD)9.84 ± 5.23
Type (s) of anti-diabetes treatment
Insulin only8226.5
Oral hypoglycemic agents (OHA) only20465.8
Both247.7
Presence of comorbid condition
No20867.1
Yes10232.9
Table 2. Physical and laboratory measurement of the T2DM patients (n = 310).
Table 2. Physical and laboratory measurement of the T2DM patients (n = 310).
ParametersMeanSD
BMI (kg/m2)32.0213.06
Waist circumference (cms)105.7516.22
Systolic BP (mmHg)132.9514.41
Diastolic BP (mmHg)79.889.65
FBS (mmol/L)8.566.96
LDL ((mmol/L)2.850.93
HDL (mmol/L)1.240.68
Total Cholesterol (mmol/L)4.651.09
TGL (mmol/L)1.680.78
Table 3. Self-management behavior patterns among the participants evaluated by the Arabic version of Summary of Diabetes Self-Care Activities (SDSCA) (n = 310).
Table 3. Self-management behavior patterns among the participants evaluated by the Arabic version of Summary of Diabetes Self-Care Activities (SDSCA) (n = 310).
Subscales/ItemsMeanSD
Diet (general and special)
1.
Followed a healthy eating plan last week
2.802.59
2.
On average, the number of days followed the diet plan in a week
2.812.62
3.
Eat five or more servings of fruits and vegetables in a week
3.672.45
4.
Evenly distribution of carbohydrates in food
3.652.52
5.
Eat high-fat foods such as red meat or whole-fat dairy products
3.832.30
Physical activities
6.
Involved in at least 30 min of physical activity (continuous such as walking)
2.652.64
7.
Participate in a specific exercise session (such as swimming, cycling)
1.842.37
Blood sugar testing
8.
Testing for blood sugar
3.782.76
9.
Number of times testing blood sugar according to the recommendation by the doctor
3.202.88
Footcare (how many days in a week)
10.
Checked the feet
1.662.55
11.
Inspect the inside of your shoes
1.422.47
12.
Washed with the soap
4.992.92
13.
Dry between your toes after washing
2.822.97
Medication
14.
Taking insulin injections according to the schedule
5.932.05
15.
Taking OHA according to the recommendation
5.722.17
Overall (mean ± SD)3.981.26
Unsatisfactory (<4) = 68.39%
Satisfactory (from 4 to 7) = 31.61%
Table 4. Relationship between each component of SDSCA and BMI values, lipid profile, and fasting blood sugar: The data presented here are Spearman’s rho/p-value (p <0.05 is a statistically significant variable).
Table 4. Relationship between each component of SDSCA and BMI values, lipid profile, and fasting blood sugar: The data presented here are Spearman’s rho/p-value (p <0.05 is a statistically significant variable).
SDSCA ItemsBMI (kg/m2)Waist Circumference (cms)Total Cholesterol (mmol/L)Triglycerides
(mmol/L)		LDL (mmol/L)HDL (mmol/L)Fasting Blood Sugar (mmol/L)
Healthy diet plan−0.160/0.005−0.252/0.001−0.071/0.212−0.172/0.002−0.069/0.2270.168/0.003−0.260/0.001
Specific diet plan−0.125/0.027−0.196/0.001−0.035/0.545−0.172/0.002−0.008/0.8820.176/0.002−0.248/0.001
Fruits and vegetables intake0.063/0.266−0.012/0.839−0.013/0.816−0.077/0.175−0.038/0.5070.107/0.61−0.133/0.019
Evenly distribution of carbohydrates in food 0.037/0.521−0.013/0.824−0.048/0.396−0.115/0.044−0.044/0.4410.103/0.069−0.151/0.008
High fat intake0.001/0.9960.013/0.8130.038/0.5020.169/0.0290.180/0.013−0.004/0.9430.021/0.712
Physical activity−0.206/0.001−0.229/0.001 −0.031/0.586−0.075/0.1880.019/0.7340.139/0.014−0.152/0.008
Specific exercise session−0.236/0.001−0.230/0.0010.032/0.574−0.137/0.0160.050/0.3780.159/0.005−0.199/0.001
Testing for blood sugar0.064/0.2610.009/0.877−0.009/0.870−0.010/0.858−0.035/0.5410.124/0.0290.031/0.582
Number of times testing blood sugar 0.051/0.3740.017/0.772−0.062/0.2780.030/0.605−0.100/0.0770.100/0.0790.001/0.984
Checked the feet0.019/0.739−0.048/0.399−0.041/0.476−0.196/0.001−0.018/0.7520.021/0.7100.007/0.905
Inspect the inside of your shoes−0.002/0.9670.025/0.662−0.075/0.187−0.209/0.001−0.059/0.2970.093/0.102−0.033/0.562
Washed with the soap0.005/0.9300.025/0.667−0.145/0.0110.013/0.817−0.164/0.0040.035/0.5440.045/0.425
Dry between your toes after washing0.026/0.644−0.015/0.788−0.145/0.426−0.012/0.835−0.031/0.5920.052/0.365−0.092/0.106
Adherence to insulin0.073/0.1980.002/0.973−0.143/0.0120.068/0.233−0.209/0.0010.080/0.161−0.311/0.001
Adherence to OHA0.161/0.0040.117/0.040−0.134/0.0180.113/0.047−0.177/0.0020.071/0.215−0.250/0.006
Table 5. Self-management behaviors and other factors associated with MS. Test applied: multivariable analysis (Binomial logistic regression).
Table 5. Self-management behaviors and other factors associated with MS. Test applied: multivariable analysis (Binomial logistic regression).
CharacteristicsTotal Participants
(n = 310)		MSUnivariate Analysis
No vs. Yes		Regression Analysis *
No vs. Yes
No (%)
n = 197		Yes (%)
n = 113		Unadjusted Odds Ratio (OR)
(95% CI)		p Value **Adjusted OR (AOR)
(95% CI)		p Value **
Age
Less than 50 years915635Ref Ref
From 50 to 60 years 12685410.77 (0.44–1.36)0.3670.79 (0.40–1.52)0.482
More than 61 years9356371.06 (0.59–1.91)0.8541.04 (0.46–2.35)0.929
Gender
Male16311053Ref Ref
Female14787602.37 (1.50–3.18)0.0261.89 (1.17–2.95)0.007
Educational Qualification
No formal education.462719Ref Ref
Primary/Preparatory/Secondary173106670.87 (0.46–1.74)0.3750.89 (0.41–1.92)0.766
University/Graduate Studies9164270.60 (0.29–1.26)0.8390.63 (0.24–1.71)0.365
Occupation
Government sector875928Ref Ref
Private sector187113.31 (1.16–5.45)0.0252.75 (0.90–5.23)0.075
Unemployed11168431.33 (0.74–2.40)0.341.12 (0.43–2.89)0.815
Retired9463311.04 (0.56–1.93)0.9090.96 (0.43–2.15)0.921
Married status
Single754233Ref Ref
Currently married 235155800.66 (0.39–1.12)0.120.71 (0.39–1.28)0.229
Monthly income in SAR (1 USD = 3.75 SAR)
Less than 5000 SAR1006436Ref Ref
From 5000 to 1000 SAR10460441.30 (0.74–2.29)0.3571.59 (0.79–3.17)0.186
More than 10000 SAR10673330.80 (0.45–1.44)0.461.11 (0.47–2.60)0.807
Smoking status
Yes633528Ref Ref
No247162851.35 (0.94–1.79)0.0681.56 (1.17–2.41)0.016
Duration of T2DM9.84 ± 5.232.19 (0.69–4.34)0.6991.93 (0.65–4.31)0.742
Type (s) of anti-diabetes treatment
Insulin824735Ref Ref
OHA204134702.05 (0.69–4.19)0.5171.95 (0.83–3.14)0.091
Both241680.89 (0.45–3.77)0.8641.22 (0.65–2.28)0.112
Self-management behavior
Satisfactory 986632Ref Ref
Unsatisfactory212131811.73 (1.03–3.17)0.0081.55 (1.11–2.87)0.027
Body mass index
Normal34277Ref Ref
Overweight 11071321.64 (0.81–2.67)0.0731.08 (0.71–1.96)0.063
Obesity (all categories)166109742.03 (1.21–3.71) 2.98 (1.31–5.07)0.003
Presence of other chronic conditions
No20813078Ref Ref
Yes10267352.21 (1.35–3.60)0.0021.74 (1.11–2.67)0.006
* Binomial logistic regression analysis (enter method) ** p-value < 0.05 is statistically significant value.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Alsaidan, A.A.; Thirunavukkarasu, A.; Alhassan, H.H.; Bin Ahmed, I.A.; Alnasiri, A.S.; Alhirsan, W.M.; Alazmi, N.N.M.; Alkhlaf, A.K.; Alderbas, J.M.; Alkhaldi, M.A. Evaluation of Self-Management Behaviors and Its Correlation with the Metabolic Syndrome among the Type 2 Diabetes Mellitus Patients of Northern Saudi Arabia. J. Clin. Med. 2024, 13, 118. https://doi.org/10.3390/jcm13010118

AMA Style

Alsaidan AA, Thirunavukkarasu A, Alhassan HH, Bin Ahmed IA, Alnasiri AS, Alhirsan WM, Alazmi NNM, Alkhlaf AK, Alderbas JM, Alkhaldi MA. Evaluation of Self-Management Behaviors and Its Correlation with the Metabolic Syndrome among the Type 2 Diabetes Mellitus Patients of Northern Saudi Arabia. Journal of Clinical Medicine. 2024; 13(1):118. https://doi.org/10.3390/jcm13010118

Chicago/Turabian Style

Alsaidan, Aseel Awad, Ashokkumar Thirunavukkarasu, Hassan H. Alhassan, Ibrahim Abdullah Bin Ahmed, Anas Salem Alnasiri, Wejdan Madallah Alhirsan, Nouf Nashmi M. Alazmi, Abdalaziz Khaled Alkhlaf, Jumanah Mohammed Alderbas, and Motaz Abdulsalam Alkhaldi. 2024. "Evaluation of Self-Management Behaviors and Its Correlation with the Metabolic Syndrome among the Type 2 Diabetes Mellitus Patients of Northern Saudi Arabia" Journal of Clinical Medicine 13, no. 1: 118. https://doi.org/10.3390/jcm13010118

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop